Scynexis Inc (SCYX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt SCYX? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Scynexis Inc Stock (SCYX) Company Profile

Scynexis Inc

Healthcare (1124)

201-884-5485

1 EVERTRUST PLAZA, JERSEY CITY, NJ

Nächster Verdiensttermin

Neueste SEC-Einreichungen

SCYX's Discussions on Twitter

Vergleichen Sie SCYX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SCYX Scynexis Inc	0.65	27.07M	3.26M	-19.52M	-24.10M	-0.40
ZTS Zoetis Inc	118.07	51.01B	9.40B	2.65B	2.24B	5.935
TAK Takeda Pharmaceutical Co Adr	14.37	45.05B	29.63B	260.53M	5.51B	0.0788
HLN Haleon Plc Adr	9.46	41.46B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	29.80	32.77B	16.70B	-157.13M	1.19B	-0.1446
UTHR United Therapeutics Corp	484.86	20.51B	3.08B	1.24B	1.07B	25.61

Scynexis Inc Stock (SCYX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2021-01-22	Eingeleitet	Guggenheim	Buy
2021-01-06	Eingeleitet	Cantor Fitzgerald	Overweight
2018-07-11	Hochstufung	Needham	Hold → Buy
2018-06-27	Eingeleitet	Maxim Group	Buy
2017-10-24	Eingeleitet	Guggenheim	Buy
2017-07-10	Eingeleitet	ROTH Capital	Buy
2017-05-09	Herabstufung	Needham	Buy → Hold
2017-03-03	Bestätigt	RBC Capital Mkts	Outperform
2016-10-20	Eingeleitet	H.C. Wainwright	Buy
2016-10-07	Hochstufung	WBB Securities	Buy → Strong Buy
2016-10-03	Fortgesetzt	Brean Capital	Buy
2016-08-17	Eingeleitet	Guggenheim	Buy
2016-08-09	Bestätigt	Needham	Buy
2016-08-09	Hochstufung	WBB Securities	Speculative Buy → Buy
2016-03-28	Eingeleitet	Brean Capital	Buy
2015-12-29	Eingeleitet	WBB Securities	Speculative Buy
2015-11-16	Bestätigt	RBC Capital Mkts	Outperform
2015-06-10	Eingeleitet	Needham	Buy
2014-05-29	Eingeleitet	Canaccord Genuity	Buy
2014-05-29	Eingeleitet	RBC Capital Mkts	Outperform

Alle ansehen

Scynexis Inc Aktie (SCYX) Neueste Nachrichten

Finanzdaten der Scynexis Inc-Aktie (SCYX)

Scynexis Inc (SCYX)

Scynexis Inc Stock (SCYX) Company Profile

Vergleichen Sie SCYX mit anderen Aktien

Scynexis Inc Stock (SCYX) Upgrades & Downgrades

Scynexis Inc Aktie (SCYX) Neueste Nachrichten

SCYNEXIS (NASDAQ:SCYX) versus NewAmsterdam Pharma (NASDAQ:NAMS) Head to Head Analysis - Defense World

Can SCYNEXIS Stock Hold Up When Markets Turn? - Trefis

Can SCYNEXIS Inc. stock surprise with earnings upsideVolume Spike & Real-Time Price Movement Reports - Newser

Why SCYNEXIS Inc. (135A) stock stays resilientWeekly Stock Report & Smart Swing Trading Techniques - Newser

How SCYNEXIS Inc. stock trades before earnings2025 Breakouts & Breakdowns & Low Drawdown Momentum Ideas - Newser

SCYNEXIS (NASDAQ:SCYX) Stock Price Crosses Below 200-Day Moving Average – Should You Sell? - Defense World

What is the fair value of SCYNEXIS Inc. stock nowEarnings Performance Report & Free Low Drawdown Momentum Trade Ideas - Newser

Is SCYNEXIS Inc. (135A) stock considered safe havenDollar Strength & Low Risk Investment Opportunities - Newser

Free cash flow per share of SCYNEXIS, Inc. – LSE:0L49 - TradingView

Working capital per share of SCYNEXIS, Inc. – LSE:0L49 - TradingView

Macro Review: Why SCYNEXIS Inc. stock is trending among retail tradersJuly 2025 Retail & Risk Adjusted Buy and Sell Alerts - BỘ NỘI VỤ

Why SCYNEXIS Inc. stock is a must watch in 2025Portfolio Gains Report & Community Verified Swing Trade Signals - moha.gov.vn

Why SCYNEXIS Inc. (135A) stock is listed among top recommendationsQuarterly Portfolio Review & Risk Managed Investment Entry Signals - BỘ NỘI VỤ

Is SCYNEXIS Inc a good long term investmentGrowth Stock Opportunities & Exceptional Return Growth - earlytimes.in

Is SCYNEXIS Inc. stock trading at a premium valuation2025 Short Interest & Stepwise Entry and Exit Trade Signals - BỘ NỘI VỤ

It is Poised to be a Bull Market for Scynexis Inc (SCYX) - Setenews

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

Investors in cash trouble should check out Scynexis Inc (SCYX) - Setenews

Will SCYNEXIS Inc. (135A) stock outperform foreign stocksJuly 2025 Action & Risk Managed Trade Strategies - newser.com

Scynexis announces grant for Hackensack Meridian, Johns Hopkins collaboration - MSN

Analyzing recovery setups for SCYNEXIS Inc. investorsFed Meeting & Fast Gain Stock Trading Tips - newser.com

Will SCYNEXIS Inc. stock recover faster than peersJuly 2025 Update & Technical Pattern Alert System - newser.com

Scynexis Transfers Brexafemme New Drug Application to GSK - MarketScreener

SCYNEXIS, Inc. Completes Transfer of Brexafungerp New Drug Application to Gsk - MarketScreener

Scynexis completes transfer of Brexafemme new drug application to GSK - MarketScreener

SCYNEXIS Completes BREXAFEMME NDA Transfer to GSK, Positioning for Future Milestones and Royalties - Quiver Quantitative

SCYNEXIS Completes Transfer of BREXAFEMME® New Drug Application to GSK - The Manila Times

Scynexis completes transfer of Brexafemme New Drug Application To GSK - TradingView

SCYNEXIS (NASDAQ: SCYX) transfers BREXAFEMME NDA to GSK, up to $145.5M - Stock Titan

Is SCYNEXIS Inc. stock attractive for passive investorsMarket Sentiment Report & Long-Term Safe Investment Plans - newser.com

How to build a dashboard for SCYNEXIS Inc. stockEarnings Overview Report & Risk Controlled Daily Trade Plans - newser.com

Scynexis fungerps among funding recipients - BioWorld MedTech

SCYNEXIS receives $7 million annual grant for antifungal research By Investing.com - Investing.com Nigeria

SCYX Secures Federal Grant for Antifungal Research - GuruFocus

Scynexis Announces Federal Funding of Collaboration Between Hackensack Meridian CDI and Johns Hopkins Researchers to Develop New Therapeutics, Including Novel Fungerps, for Resistant Fungal Infections - The Manila Times

SCYNEXIS Receives $35 Million NIH Grant to Develop Next-Generation Antifungal Therapies - Quiver Quantitative

Scynexis (NASDAQ: SCYX) fungerps program included in $7M NIH CETR grant - Stock Titan

Why SCYNEXIS Inc. (135A) stock benefits from AI revolutionForecast Cut & AI Forecast Swing Trade Picks - newser.com

Live market analysis of SCYNEXIS Inc.July 2025 Recap & Community Verified Trade Signals - newser.com

Will SCYNEXIS Inc. (135A) stock deliver stable dividendsJuly 2025 Closing Moves & Weekly Top Gainers Alerts - newser.com

How geopolitical tensions affect SCYNEXIS Inc. stockEarnings Recap Summary & Consistent Return Investment Signals - newser.com

Finanzdaten der Scynexis Inc-Aktie (SCYX)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie SCYX